BCM
ENZ

Bluefin Capital Management’s Enzo Biochem, Inc. ENZ Stock Holding History

Bluefin Capital Management’s Portfolio ENZ Stock Details ENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-26,621
Closed -$121K – 635
2016
Q1 		$121K Sell
26,621
-19,561
-42% -$87.1K 0.01% 336
2015
Q4 		$208K Buy
+46,182
New +$195K 0.02% 408

Other funds holding ENZ

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

Bluefin Capital Management's ENZ Position: Q2 2016 in Review

Bluefin Capital Management sold out of Enzo Biochem, Inc. (ENZ) in Q2 2016, closing a stake of 26,621 shares — an estimated $121K sold.

Bluefin Capital Management first reported a position in ENZ in Q4 2015 and held it in 2 quarters. The position peaked at $208K in Q4 2015. 104 funds tracked by Wall St. Rank hold ENZ as of Q2 2016.

  • Bluefin Capital Management reported no remaining Enzo Biochem, Inc. position as of Q2 2016 after selling out during the quarter.
  • Bluefin Capital Management sold 26,621 Enzo Biochem, Inc. shares in Q2 2016, an estimated $121K.
  • Bluefin Capital Management first reported a position in Enzo Biochem, Inc. in Q4 2015 and held it in 2 quarters.
  • Bluefin Capital Management's Enzo Biochem, Inc. position peaked at $208K in Q4 2015.
  • 104 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q2 2016.

Based on Bluefin Capital Management's 13F filing for Q2 2016, filed 16 Aug 2016.